文献速递白血病

血浆脂质水平预测急性髓系白血病的化疗反应和生存

Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia.
PubMed 文献 · Blood · 2025-01-01

研究对231例初诊急性髓系白血病(AML)患者化疗前血浆进行无偏代谢组学和脂质组学分析,发现循环代谢物与AML细胞突变状态高度相关,脂质与难治状态相关;基于难治相关脂质建立的机器学习算法可预测患者生存,其中鞘磷脂(d44:1)足以在原数据集和独立验证数据集中预测总生存。

要点

  • 循环代谢物与AML细胞突变状态高度相关。
  • 脂质与化疗难治状态相关,基于难治相关脂质构建的机器学习算法可预测生存。
  • 高风险脂质特征中的首要脂质鞘磷脂(d44:1)足以预测总生存,并在独立验证数据集中得到验证。

核心结论

  • 循环代谢物可反映AML异质性,脂质有潜力作为AML生物标志物。

研究设计与样本

  • 对231例初诊AML患者化疗前血浆样本进行无偏代谢组学和脂质组学分析,并建立机器学习算法预测生存。

主要发现

  • 循环代谢物与AML细胞突变状态高度相关。
  • 脂质与难治状态相关。
  • Cox回归和Kaplan-Meier分析显示高风险脂质特征可预测该患者队列的总生存。
  • 高风险脂质特征中的首要脂质鞘磷脂(d44:1)足以在原数据集和独立验证数据集中预测总生存。

关键数值与推荐

  • 高风险脂质特征中的首要脂质为鞘磷脂(d44:1)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute myeloid leukemia (AML) is characterized by a low 5-year survival rate. Despite having many clinical metrics to assess patient prognosis, there remain opportunities to improve risk stratification. We hypothesized that an underexplored resource to examine the prognosis of patients with AML is plasma metabolome. Circulating metabolites are influenced by patients' clinical status and can serve as accessible cancer biomarkers. To establish a resource of circulating metabolites in genetically diverse patients with AML, we performed an unbiased metabolomic and lipidomic analysis of 231 diagnostic AML plasma samples before treatment with intensive chemotherapy. Intriguingly, circulating metabolites were highly associated with the mutation status within the AML cells. Furthermore, lipids were associated with refractory status. We established a machine learning algorithm trained on chemotherapy-refractory-associated lipids to predict patient survival. Cox regression and Kaplan-Meier analysis demonstrated that the high-risk lipid signature predicted overall survival in this patient cohort. Impressively, the top lipid in the high-risk lipid signature, sphingomyelin (d44:1), was sufficient to predict overall survival in both the original data set and an independent validation data set. Overall, this research underscores the potential of circulating metabolites to capture AML heterogeneity and lipids to be used as potential AML biomarkers.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. O'Brien C, Nursimulu N, Tyagi A, et al. Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia. Blood. 2025. PMID: 40857673. doi:10.1182/blood.2025029132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。